Elopak's analyst price target has seen a slight decrease, from NOK 52.84 to NOK 52.82, as analysts adjust their models to reflect modest changes in revenue growth estimates and minor shifts in profit margin expectations.
What's in the News
- Elopak ASA (OB:ELO) has been added to the S&P Global BMI Index. (Key Developments)
- The company commenced share repurchases on September 15, 2025, following a shareholder mandate authorizing the purchase of up to 10% of share capital. The authorization is valid until the 2026 annual general meeting or June 30, 2026. (Key Developments)
- From April 1, 2025 to May 14, 2025, Elopak completed the repurchase of 600,000 shares for NOK 23.57 million under its buyback program. No shares were repurchased in the most recent period. (Key Developments)
Valuation Changes
- Fair Value Estimate has decreased slightly from NOK 52.84 to NOK 52.82.
- Discount Rate has risen marginally, moving from 6.62% to 6.63%.
- Revenue Growth is forecast to be higher, with projections increasing from 6.74% to 6.92%.
- Net Profit Margin expectations have edged up from 7.03% to 7.07%.
- Future Price-to-Earnings (P/E) ratio has declined from 14.65x to 14.51x.
Have other thoughts on Elopak?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.